Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Egyptian Rheumatology and Rehabilitation. 1999; 26 (4): 827-844
Dans Anglais | IMEMR | ID: emr-50667

Résumé

The present study was performed on twenty-five SLE patients. They were classified according to Doppler Echocardiographic findings into 2 groups: Group I: included 17 patients [68%] [15F, 2M] who had cardiac affection. Their disease duration ranged from 6 months to 10 years while the range of SLEDAI score was 4-22 with a mean of 10.6 +/- 5.3. Group II: included 8 females without cardiac affection. The range of disease duration was from 8 months to 6 years while SLEDAI score ranged from 4 to 21 with a mean of 11.1 +/- 6.02. There was a statistical significant difference between the 2 groups [p<0.05] as regards arthritis, fever and CNS symptoms that were present in 2 patients of group II only. Also there were significant differences between the two groups [p<0.05] as regards the ESR, anti-DNA and lupus anticoagulant. But lipograms did not show any statistical difference between both groups [p>0.05]. There was a direct correlation between pericarditis and disease activity and anti-DNA titer, as well as a significant positive correlation between valvular affection and lupus anticoagulants but a negative correlation between systolic function and activity as well as anti-DNA titer. Lastly, no significant correlation was found between cardiac involvement and the duration of the disease or duration of steroid therapy used or with lipograms. So Doppler-Echocardiography was helpful in showing that cardiac involvement was frequent in SLE patients especially during disease activity. Again, lupus anticoagulant [LAC] is common is SLE with cardiac involvement. So cardiovascular system must be investigated well especially in patients with positive LAC for the importance of planning therapy and assessment of prognosis


Sujets)
Humains , Mâle , Femelle , Système cardiovasculaire , Échocardiographie-doppler , Anticorps antinucléaires , Cholestérol HDL , Cholestérol LDL , Triglycéride , Évolution de la maladie
SÉLECTION CITATIONS
Détails de la recherche